270 related articles for article (PubMed ID: 16377382)
21. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
Webb L; Gilg J; Wilkie M
Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
[TBL] [Abstract][Full Text] [Related]
22. The clinical efficacy of higher hematocrit levels in children with chronic renal insufficiency and those undergoing dialysis.
Yorgin PD; Belson A; Al-Uzri AY; Alexander SR
Semin Nephrol; 2001 Sep; 21(5):451-62. PubMed ID: 11559886
[TBL] [Abstract][Full Text] [Related]
23. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
Lacson E; Ofsthun N; Lazarus JM
Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
[TBL] [Abstract][Full Text] [Related]
24. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.
Regidor DL; Kopple JD; Kovesdy CP; Kilpatrick RD; McAllister CJ; Aronovitz J; Greenland S; Kalantar-Zadeh K
J Am Soc Nephrol; 2006 Apr; 17(4):1181-91. PubMed ID: 16565261
[TBL] [Abstract][Full Text] [Related]
25. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin levels, quality of life, and survival.
Sadler JH; Meyer KB
Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
[No Abstract] [Full Text] [Related]
27. Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron.
Trivedi HS; Brooks BJ
Am J Nephrol; 2003; 23(2):78-85. PubMed ID: 12481145
[TBL] [Abstract][Full Text] [Related]
28. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
29. Cardiac function and hematocrit level.
Harnett JD; Kent GM; Foley RN; Parfrey PS
Am J Kidney Dis; 1995 Apr; 25(4 Suppl 1):S3-7. PubMed ID: 7702071
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials.
Ye Y; Liu H; Chen Y; Zhang Y; Li S; Hu W; Yang R; Zhang Z; Lv L; Liu X
Ren Fail; 2018 Nov; 40(1):671-679. PubMed ID: 30741617
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
32. Anemia Evaluation and Erythropoietin Dose Requirement Among Hemodialysis Patients: a Multicenter Study.
Nafar M; Samavat S; Khoshdel A; Alipour-Abedi B
Iran J Kidney Dis; 2017 Jan; 11(1):56-65. PubMed ID: 28174354
[TBL] [Abstract][Full Text] [Related]
33. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
34. Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States.
Snyder JJ; Foley RN; Gilbertson DT; Vonesh EF; Collins AJ
J Am Soc Nephrol; 2004 Jan; 15(1):174-9. PubMed ID: 14694170
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
[TBL] [Abstract][Full Text] [Related]
36. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J
Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840
[TBL] [Abstract][Full Text] [Related]
37. Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure.
Ksiazek A; Baranowska-Daca E
Perit Dial Int; 1993; 13 Suppl 2():S550-2. PubMed ID: 8399662
[TBL] [Abstract][Full Text] [Related]
38. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
[No Abstract] [Full Text] [Related]
39. Reasons for producing guidelines on anemia of chronic renal failure: dialysis outcome quality initiative of the National Kidney Foundation.
Triolo G; Canavese C; Di Giulio S
Int J Artif Organs; 1998 Nov; 21(11):751-6. PubMed ID: 9894755
[TBL] [Abstract][Full Text] [Related]
40. The optimal hemoglobin in dialysis patients- a critical review.
Singh AK; Fishbane S
Semin Dial; 2008; 21(1):1-6. PubMed ID: 18251947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
